Keywords: king, sees, 1st-qtr, earnings, drop, 51m, company
King sees 1st-qtr earnings drop 28% to $51M
Article | 29 May 2006
US company King Pharmaceuticals says that its net earnings for the first-quarter ended March 31, 2006, declined 28% to $51.0 million, or $0.21 diluted earnings ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
